Navigation Links
University of Maryland, Baltimore BioPark Signs Gliknik Inc. as First Tenant in Its BioInnovation Center in Building Two
Date:1/9/2008

knik's lead compounds are novel T cell vaccines in clinical safety studies. Gliknik also has created recombinant mimetics of intravenous immune globulin and recombinant mimetics of monoclonal antibodies. For further information, please visit http://www.gliknik.com.

About Wexford Science+Technology

A wholly owned subsidiary of Wexford Equities, LLC, Wexford Science+Technology is a privately held real estate investment and development company based in Baltimore, MD. With a team of real estate, finance and engineering experts, Wexford is devoted to developing innovative real estate solutions that inspire creativity and advance new technologies. For more information, please visit http://www.wexfordequities.com.

About UMB BioPark

The University of Maryland, Baltimore BioPark offers sophisticated laboratory and office space for early-stage to mature bioscience companies. To date, the UMB BioPark includes 360,000 square feet in two multi tenant buildings and one 638 space parking garage. The project has created 200 jobs and $128 million in capital investment. The BioPark was named by the Association of University Research Parks as the best emerging research park on the year in October 2007. For more information, please visit http://www.umbbiopark.com


'/>"/>
SOURCE Gliknik Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
2. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
3. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
4. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. University of Leicester scientists discover technique to help friendly bacteria
7. MichBio Announces Student Career Day at Michigan State University
8. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
9. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
10. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
11. McGill University Purchases GenVaults Personal Archive System to Manage Rare Cancer Samples
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)... 2 /- Aureus Pharma, a leading provid... discovery in the life science,industry, announced...will,be held in Paris on October 23rd and 24th., ...ul inaugural event,which was attended by many of A...oth Europe and North America. The symposium includ...
(Date:7/2/2008)...Advance Commercialization of Expanded Portfolio of... VANCOUVER, British Columbia, July 2 /PRNewswire/...tures Corp. (TSXV: MEV), a company developing and,...oday announced its name,change and the expansion o...the acquisition of two vascular product developmen...
(Date:7/2/2008)...oints to potential of pre-treatment R2 levels as a... activity -, TORONTO, July 2 /PRNewswire-FirstCal... ("Lorus" or the "Corporation"), a biopharmaceutic...pment of pharmaceutical products and,technologies ...ication by,an Ohio State University (OSU) clinical...
(Date:7/1/2008)... N.J., July 2 /- Schering-P...e successful closing of its,previously announced t...th,products from selected franchises. These divest... part of its October 2007 clearance of the,acquisi...ac acquired products from the endocrine, mastitis ...
Breaking Biology Technology:Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
... Isolate and Enrich for Bacterial mRNA ,...icroarray Analysis , The rapid increase i...omes sequenced over the past , ...ome , expression analysis using... years, this tool has been used to explore...
... , No more siRNA design a... complete in 1 day , ...paration, RNase , III digestion and siR... Silencing Experiments The , ...) to induce targeted gene , sil...
...t Full-length cDNA , Ambion scientists ...nscriptase , to improve production of ful...se, , <A , href="http:...ipt , (patent pending), produces signifi...A than wild type RTs, and rivals even the newest e...
...bion now offers a complete Gene Expression Profili...s. From basic data analysis to our Full Service of...all. The Full Service offering includes , c...y and informatics scientists , and comprehe...iding innovative, , high quality products a...
Other Biology Technology:Bacterial Whole Genome Array Analysis 2Bacterial Whole Genome Array Analysis 3Bacterial Whole Genome Array Analysis 4Bacterial Whole Genome Array Analysis 5Bacterial Whole Genome Array Analysis 6Bacterial Whole Genome Array Analysis 7Avoid siRNA Design Altogether! 2Avoid siRNA Design Altogether! 3ArrayScript RT: Maximize Yields of Full-length cDNA 2ArrayScript RT: Maximize Yields of Full-length cDNA 3Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3
(Date:7/2/2008)...want to produce a lot of a substance -- such as a ...s, molecules that speed chemical reactions. Many j...ing one in just the right shape to connect with ce...s, such as enzymes in the human body that help us ...ting to suit the task at hand. , Chemists have m...
(Date:7/2/2008)...erman . , Metabolomics aims to determine the tot.... The exponents of bioinformatics analyzed data co...omics study in healthy and diabetic mice. In each ...he diabetes drug RoziglitazoneTM. Then, more than ...a blood plasma sample of a total of forty mice, re...
(Date:7/2/2008)...Spanish . , Most of the functions performed by ...eins, which recognise their binding partner by aff...here are many kinds of interactions; however, the ...structural biology are those which are transient. ...gh a large section of the protein surface- the glo...
(Date:7/2/2008)... of its kind, using sophisticated methods to measu...al weight loss program, Weight Watchers, was compa...ethod wins in the game of good health. A Universit...periences of participants to determine which progr...ain health benefits. The answer is that both have ...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 1Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 1Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 3Teenage Drinking Can Spell Lasting Trouble 1742 1Teenage Drinking Can Spell Lasting Trouble 1742 2Teenage Drinking Can Spell Lasting Trouble 1742 3Pathway to cell death redefined in landmark study 1739 1Pathway to cell death redefined in landmark study 1739 2Pathway to cell death redefined in landmark study 1739 3Pathway to cell death redefined in landmark study 1739 4
...fied a cell population that is a primary target of...poral dementia, which is as common as Alzheimer,s ...e 65. , Because the cells arose only recently in ...eat apes and humans-- and are particularly abundan...that evolution has rendered the human brain vulner...
... an antibiotic in a non-native host has provided a... at Urbana-Champaign with the potential for develo...e rapid rise of antibiotic resistance poses a seri...ents effective against resistant pathogens. Fosfom...and Drug Administration for the treatment of vario...
...ffer hearing loss due to the toxic effects of chem...g back through pharmacological and gene therapy, t...hildren,s Research Hospital. Mice with a variety o...f the ear will also help scientists understand age...g loss caused by long-term exposure to loud noise,...
...from global warming? Perhaps, but the tradeoffs in...uclear waste generated each year and a greatly inc...version of nuclear material into terrorists, hands... Rodney Ewing, who has analyzed just how much nucl...ly reduce greenhouse gas emissions worldwide, and ...
Other Biology News:Study offers window into human behavior, brain disease 2Study offers window into human behavior, brain disease 3Study offers window into human behavior, brain disease 4Cloning techniques produce FDA-approved antibiotic 2St. Jude finds clues to hearing loss from chemotherapy 2Plutonium or greenhouse gases? Weighing the energy options 2
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays.
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays.
Request Info
QML offers standard and customized paraffin embedded tissue blocks.
Biology Products: